Suzanne Meeks
Family · Portage, INNPI 1679746044
Payments from drug & device makers
Across 241 payments — averaging $16.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$766
- Novo Nordisk$511
- Boehringer Ingelheim$348
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$341
- Merck$241
- AstraZeneca$240
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,81097%
- Education$1253%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $766 |
| Novo Nordisk | 30 | $511 |
| Boehringer Ingelheim | 26 | $348 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 27 | $341 |
| Merck | 15 | $241 |
| AstraZeneca | 14 | $240 |
| Lilly USA, LLC | 9 | $173 |
| Pfizer | 7 | $146 |
| Astellas Pharma US Inc | 7 | $144 |
| Novartis | 8 | $139 |
| Grifols USA, LLC | 5 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $105 |
| Abbott | 5 | $96 |
| Otsuka America Pharmaceutical, Inc. | 4 | $91 |
| Alnylam Pharmaceuticals Inc. | 2 | $51 |
| Biohaven Pharmaceuticals, Inc. | 2 | $47 |
| GSK | 3 | $46 |
| Antares Pharma, Inc. | 2 | $38 |
| Amgen | 2 | $36 |
| IBSA Pharma Inc. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Johnson & Johnson | 2 | $26 |
| Halozyme Inc | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Bausch Health US, LLC | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$3,935 in reported general payments places this provider in the 90th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 77 | $95,947 |
| JanuviaSitagliptin Phosphate | 64 | $76,174 |
| FarxigaDapagliflozin Propanediol | 54 | $65,752 |
| OzempicSemaglutide | 29 | $56,949 |
| Xigduo XrDapaglifloz Propaned/Metformin | 25 | $26,370 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $25,764 |
| EliquisApixaban | 17 | $25,364 |
| JardianceEmpagliflozin | 23 | $24,811 |
| LinzessLinaclotide | 16 | $22,879 |
| XareltoRivaroxaban | 18 | $20,545 |
| TradjentaLinagliptin | 11 | $16,116 |
| Breo ElliptaFluticasone/Vilanterol | 21 | $14,315 |
| Repatha SureclickEvolocumab | 11 | $13,840 |
| Nebivolol Hcl | 34 | $5,367 |
| VyvanseLisdexamfetamine Dimesylate | 11 | $3,884 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $173 | $95,94777 claims |
| MerckJanuvia | $241 | $76,17464 claims |
| AstraZenecaFarxiga | $240 | $65,75254 claims |
| Novo NordiskOzempic | $511 | $56,94929 claims |
| Boehringer IngelheimJardiance, Tradjenta | $348 | $40,92634 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $46 | $40,07944 claims |
| PfizerEliquis | $146 | $25,36417 claims |
| AbbVieLinzess, Synthroid | $766 | $24,36145 claims |
| Johnson & JohnsonXarelto | $26 | $20,54518 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $105 | $3,88411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,392 family providers in Indiana.
Other family in Portage
- Robin AndersonPortage$333K
- Nancy ArndtPortage$91K
- Melanie HaneyPortage$13K
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.